Drugs / gpASIT+TM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00833066 | Feb → Oct 2009 | seasonal allergic rhinitis | BioTech Tools S.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gpASIT+TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00833066 ↗ |
| Modality | Peptide | “Grass Pollen-derived Peptides” NCT00833066 ↗ |
| Route | Oral | “oral administration of grass pollen peptides” NCT00833066 ↗ |